CSBR (Champions Oncology, Inc.) Stock Analysis - SEC Filings

Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CSBR SEC filings?

Rallies organizes CSBR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CSBR Key Metrics

Key financial metrics for CSBR
MetricValue
Price$5.99
Market Cap$84.29M
P/E Ratio17.65
EPS$0.34
Dividend Yield0.00%
52-Week High$11.99
52-Week Low$3.75
Volume0
Avg Volume0
Revenue (TTM)$56.94M
Net Income$4.70M
Gross Margin50.15%

Latest CSBR News

Recent CSBR Insider Trades

  • Mendelson Daniel Newman bought 1.00K (~$6.50K) on Jan 12, 2024.
  • Mendelson Daniel Newman bought 2.00K (~$12.54K) on Jan 11, 2024.
  • Mendelson Daniel Newman bought 2.94K (~$18.58K) on Jan 10, 2024.

CSBR Analyst Consensus

CSBR analyst coverage data. Average price target: $0.00.

Common questions about CSBR

Where can I find CSBR SEC filings?
Rallies organizes CSBR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CSBR 10-K and 10-Q filings?
Rallies organizes CSBR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CSBR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.
CSBR

CSBR